We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Amryt Pharma Plc | LSE:AMYT | London | Ordinary Share | GB00BKLTQ412 | ORD 6P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 143.00 | 151.00 | 170.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
12/4/2019 21:21 | mdalos1 12 Apr '19 - 20:42 - 4369 of 4369 0 0 0 £500 !!!! (@ 12.3p presumably) LOLs >>>>> Yes, 12.30p, mdalos. Not the 2.30p I incorrectly posted in post 4368, but you never know perhaps I was predicting the future AMYT sp!! LOL. LOL. | papillon | |
12/4/2019 12:03 | My mistake yesterday was correct! LOL. The results RNS will be Wednesday 17th | papillon | |
12/4/2019 07:23 | Just looking on advfn AMYT quote and it showing 52 week range as ....12.32 to 1,232,500,000.00 .....dam if I'd have seen that price at the right time I would have sold one share and kept the rest !!! Lol | richpassi | |
11/4/2019 16:38 | I briefly met with them at the UKIS show. Didn't go to presentation, however I did probe about the next Lox deal and where they were. I was a little disappointed that they didn't have anything in the immediate offing, however he was clear they would expect to have sign something up before the year-end. They did say that they have looked and done due diligence on a number of products, but they are being very cautious to make sure the sums add up, which is sensible. Hopefully Lox numbers are continuing to show good growth, as I like a biotech with revenues but I guess it's all on AP101, which they were keen to talk about. | waterloo01 | |
11/4/2019 16:13 | I agree, Tiananmen, AMYT could be a good gamble at this price. That's why I'm holding. | papillon | |
11/4/2019 15:54 | We can all get it wrong at times and AIM stock adds to the uncertainty, I suspect Davy get it right more times than they get it wrong. FT also have a similar forecast at 72p. The main point is that circa 12p is very attractive at the minute | tiananmen | |
11/4/2019 15:05 | Actually the 15th is Monday, not Wednesday, as I erroneously mentioned in my previous post. So Irish broker Davy gives a 93p share price target and a 75% chance of success with the AP101 trial. I remember Davy gave a price target of £23 to PVR when the share price was around £7 about 6 years ago. The PVR share price now? Just over 12p!!!!!! So I'd take any target for AMYT from Davy with a very large pinch of salt. Of course I hope they are correct! Fingers crossed. | papillon | |
11/4/2019 11:36 | https://www.davysele | tiananmen | |
11/4/2019 11:14 | mdalos1 11 Apr '19 - 09:19 - 4357 of 4358 0 0 0 Glutton for punishment wanting those "Results"... it isn't going to be good News. >>>>> Could be mdalos. Just a small gamble for me. Only got around £1k invested in AMYT. PS. Neither you, nor I, know whether the "Results" will contain good, or bad, news. Fingers crossed it's the former. PPS. If you are correct Tiananmen, that means next Wednesday. | papillon | |
11/4/2019 09:59 | Apparently on the 15th of Apr | tiananmen | |
10/4/2019 21:14 | Wonder when the 2018 Final Results RNS will be issued? Must surely be soon? Next week? | papillon | |
03/4/2019 22:55 | mdalos1 3 Apr '19 - 19:44 - 4354 of 4354 0 0 0 Like a dead Cat it will "bounce" a bit. Only +ve news about Sales/revenue or the Gene Therapy venture or eventual AP101 Trial results will give this any sort of more permanent uplift to 17p and maybe back into the 20s. Sales/revenue is likely to simply remain "steady" The whole Gene Therapy venture is a medium to long-term exercise... really wouldn't expect anything too significant this year or next on that front. AP101... well... dragging it's heels now to this year-end and might still be a flop. This has got 8.5p written all over it to the Autumn without something +ve on any 1 of the 3 strands listed above. >>>>> 8.5p? You could be right, mdalos. I hoping for a dead cat bounce up to the 200 day EMA (currently 15.8p and very slowly falling) following the 2018 Final Results RNS. I'm hoping that Lojuxta revenue is exceeding market expectations. I haven't got long to wait to find out my fate. | papillon | |
03/4/2019 13:56 | Was always thus Pap, small pharma like the oilers are super high risk but I trade on narrow margins so my losses will be modest regardless.I do think the chart looks interesting from a contrary perspective... time will tell if we'll both be begging on the high street or ordering that second private jet, all imo dyor ofc. | rathean | |
03/4/2019 12:24 | I had to see who this 'Bronxville' person is and found that he posts on the LSE chat board. By all accounts what he has been saying for months is correct.He has been warning about Amryt since the share price was trading in the 18-16 range. He has been saying that AP101 efficacy is only marginally better than the placebo.that Amryt have not signed a new drug since Lojuxta over 2 years ago.that there are too many executives on big salaries.and more recently that Amryt will have to do a raise more cash. (He had be positive on the gene therapy treatment but said he thought it was further along) I honestly do not have a clue why Papillion is disparaging him. Mind you. Bronxville is not a big fan of Papillion either. | chica1 | |
03/4/2019 10:27 | backing a donkey here pappy did try and warn you multiple times.... | purple11 | |
03/4/2019 10:25 | I suspect investors, Rathean, are worried about a cash call and at what price? Regarding the chart, yes the RSI is in oversold territory, but there is no limit to how long it can stay oversold. Look at the chart I posted last night. It's only a 6 month chart, but shows the RSI was oversold (below 30) for all of November & December, whereas currently the RSI has only been oversold for under a month. I expected a rise in the share price in the lead up to the 2018 final results possibly due the middle of this month, but it hasn't happened so far. I've only had a very modest punt recently on AMYT so if the share price continues to fall it's not the end of the world for me. I've been tempted to have another small punt this morning, but I've resisted the temptation. A £1k punt is enough for me. | papillon | |
03/4/2019 08:53 | Just dipped my toe back in, chart looks oversold and I see nothing in the recent rns to warrant a sell off... although this has been unloved since adding to my watchlist. Worth a punt at this share price with results due imo dyor ofc. | rathean | |
02/4/2019 22:35 | An AMYT log chart specifically for that know it all, Bronxville. It shows the AMYT share price drifting lower and lower. I can't predict share prices (unlike Bronxville) so I have no idea how much longer the AMYT share price will drift lower and where it will bottom (if it does bottom!). free stock charts from uk.advfn.com | papillon |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions